Transforming Lives with Light
Game Changing Cardiovascular and Dermatological Therapies
We are dreamers and doers, scientists and entrepreneurs, more tenacious than the diseases we treat. We are innovators and pragmatists, delivering trailblazing devices that are better, safer, faster, cheaper. We change lives – and the status quo. We are the last hope for many patients and the best choice for many physicians. We are the chance for a changed life. And we shoulder this great responsibility with unshakable dedication. We are Ra Medical Systems.
Better. Safer. Faster. Cheaper.
- Pioneers of cardiovascular and dermatology catheters and excimer lasers
- More than a decade of proven clinical success worldwide
- Millions of treatments performed
- Hundreds of thousands of patients treated
- Unmatched safety and ease of operation
- CE mark, ISO 9001, and ISO 13485 certifications
- Affordable and profitable acquisition options for physicians
- Reimbursed and accessible for patients
Dr Airoldi describes how DABRA advances with a gentle push and makes the turns in hard calcium, tracking the native vessel without a wire, below the knee. Patient has renal failure and is on dialysis.
“The Catheter itself performed the 2 curves and the straight portion of the artery.”
Flavio Airoldi, MD. Multimedica, Italy
The Pharos Excimer Laser “has been a great addition to our practice. Our patients have loved the results, especially our vitiligo, and psoriasis patients.”
Sidney B. Smith, MD
The Story Behind Ra Medical Systems’ Journey to Transform Lives with Light
Meet the scientists and entrepreneurs behind the company that is saving and changing the lives of millions of people worldwide. The founders of Ra Medical Systems take us back to the beginning and share how their core mission to create better, safer, faster, and cheaper technologies to improve patient care and lower the costs of healthcare led to the creation of 2 game-changing technologies: Pharos, which sends dermatological diseases including psoriasis and vitiligo into remission and; DABRA, which has life-saving potential by unclogging arteries.
Breaking Stories From Our Newsroom
In addition to advancing cardiovascular and dermatological medicine, Ra Medical Systems is committed to keeping physicians, patients, and shareholders up-to-date on our latest news. Visit our Newsroom for complete press releases, news coverage, and videos of DABRA, Pharos, and Ra Medical Systems.
Ra Medical Systems in the News
Healthcare Has Healthy Impact on San Diego Real Estate
Healthcare and related industries continue to exert growing impact on demand for commercial real estate in San Diego County. Among the latest examples is developer Sudberry Properties’ ground-breaking for a second 158,000-square-foot office building at the Scripps Ranch headquarters of client MedImpact Healthcare Systems Inc., a major provider of pharmacy Read More...
24 CEOs and Execs on the Daily Habits That Made Them Successful
Ra Medical Systems’ CEO, Dean Irwin, has been a part of a trending inspirational article. Originally published by Inc., the article quoted 24 CEOs and executives on their daily habits that have contributed to their success. Irwin’s habit of choice is perseverance! The article is now being featured in Thrive Read More...
Following FDA Approval for PAD, Ra Medical Steps Up Hiring
Carlsbad, Calif.-based RA Medical Systems closed out 2017 with the launch of its newly approved peripheral artery disease (PAD) treatment. Ra’s DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) system became available to customers in October after receiving a May approval from the U.S. Food and Drug Administration. The company currently has its system Read More...
Medtech Cos. Look to Derail Device Tax
San Diego — Carlsbad’s Ra Medical Systems is among the medtech companies that say the return of a 2.3 percent excise tax on medical devices sold in the U.S. threatens expansion and hiring plans. Congress failed to deliver on promises to kill the tax, which resumed Jan. 1 after a two-year Read More...
Office-Based Cath Labs May be a New Model for Treating Peripheral Artery Disease
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings across the nation, there appears to be very little common ground upon which stakeholders agree. Yet common aspirations that are shared by most participants include better patient care, better clinical outcomes and Read More...
Ra Medical Co-Founder Burstein Touts Innovation, Planning and Caring as Keys to Success for Medtech Execs
To access the article on MassDevice's website click here. By: Fink Densford This year has been an exciting one for Ra Medical, maker of the DABRA arteriosclerosis laser designed to treat peripheral artery disease. In May, the Carlsbad, Calif.-based company received a nod from the FDA for the DABRA, clearing it for sale Read More...
Interview with CEO of Ra Medical Systems
To Access the article on MedGadget website click here. written by: Alice Ferng More than 200 million people worldwide, including approximately 8.5 million Americans, suffer from Peripheral Artery Disease (PAD). In the U.S. and Europe, PAD is responsible for around 240,000 amputations every year. Nearly a quarter of patients die within 30 Read More...
Ra Medical Systems Receives FDA Clearance for Laser Ablation
To access the article on Photonics Media's website click here. CARLSBAD, Calif. — In an effort to battle Peripheral Artery Disease (PAD), the leading cause of limb amputations, the FDA has granted market clearance to laser developer Ra Medical Systems Inc., makers of excimer lasers and catheters for cardiovascular and Read More...
Ra Medical CEO Irwin Aims for Feb 2018 IPO
To access the article on MassDevices' website click here. In May, Ra Medical received a nod from the FDA for its DABRA arteriosclerosis laser, clearing it for use in the US. It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an interview, and signaled a Read More...
Ra Medical Systems to Present at 2018 Biotech Showcase
CARLSBAD, Calif. – January 4, 2018 – Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, announced today that the Company’s CEO and Chief Technology Officer, Dean Irwin, will present at the 10th Annual Biotech Showcase™, taking place on Jan. 8 through 10, 2018, in Read More...
Ra Medical Systems Granted Broad Patent for DABRA Catheter for Cardiovascular Disease Treatment
Catheter’s Liquid Fill with Solid Window Surface Provides Improved Tissue Removal, Contributing to DABRA’s 95 Percent Success Rate CARLSBAD, CA. – July 17, 2017 Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, today announced that the United States Patent and Trademark Office (USPTO) has Read More...
Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors
Carlsbad, CA – July 11, 2017 Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation (NASDAQ:SPNC) by Royal Philips (NYSE:PHG), Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the appointment of two new members to the Company’s Board of Directors. This also Read More...
Doctor Begins First Commercial, FDA-Cleared, in Patient Use to Treat Peripheral Artery
San Antonio, TX - June 20, 2017 Today, the Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, to use its groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease (PAD) in order to combat Read More...
Ra Medical Systems’ DABRA Begins First Commercial, FDA-Cleared, In-Patient Use
New Orleans, LA—June 1, 2017 (BUSINESS WIRE) Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the commercial launch in the United States of the Company’s groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease. This follows FDA clearance earlier this week. Dr. Athar Read More...
Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment. The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. The single-use catheter produces a lumen while minimizing trauma Read More...
FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment
Media Contacts Caitlin Kasunich / Lisa Lipson KCSA Strategic Communications 212.896.1241 / 508.843.6428 [email protected] / [email protected] Investor Contacts Jeffrey Kraws President, Ra Medical Systems 609.306.2274 [email protected] Game- Changing DABRA System Removes Blockages from Arteries to Save Limbs and Lives CARLSBAD, Calif. – May 30, 2017 – In an effort to Read More...
Ra Medical Systems’ DABRA Atherectomy System Launched in Northern Europe
April 12, 2017 Ra Medical Systems, a maker of excimer lasers and catheters for cardiovascular diseases as well as dermatological diseases, and Bo Medical Technologies, a multinational medical device sales and service distributor, recently announced the launch of the DABRA atherectomy system in Europe. In October 2016, Ra Medical announced Read More...
DABRA Cardiovascular Testimonials
Pharos Dermatology Testimonials
- Dr. Mahmud describes the first-ever DABRA case performed. The patient presented with a short SFA lesion, not crossable with a wire. DABRA crossed and re-canalized the vessel, after which angioplasty with a low pressure balloon at 2 atmospheres was performed. No drug coated balloons or stents were used, and there was no dissection. The patient remains asymptomatic 4 years post-procedure. “It was remarkable. It was very smooth. It was successful, and 4 years later the patient remains patent.” Ehtisham Mahmud, MD, FACC, FSCAII, UC San Diego Cardiovascular Clinic... Continue Reading
- Dr. Jacobson's daughter is 8 years old and has suffered from scalp psoriasis for 2 years. Despite twice-daily intensive topical treatments and medications prescribed by her dermatologist mom, her psoriasis continued to worsen. She had itchy, scaly sores on her scalp and behind her ears that she constantly scratched. Most days she was pretty uncomfortable and often distracted at school because of her psoriasis. Knowing that the next step had to be taken, Dr. Jacobson chose to treat her daughter with the Pharos excimer laser. After just 3 weeks of treatment with the Pharos, Dr. Jacobson's daughter had…... Continue Reading